Last updated: August 10, 2025
Introduction
Singapore Patent SG11201704066V, filed in 2017, pertains to a novel pharmaceutical invention with potential implications across various therapeutic areas. This patent's scope and claims define its legal protective boundaries and inform market exclusivity, competitive landscape, and licensing opportunities. Analyzing this patent within the broader intellectual property (IP) landscape provides critical insights for stakeholders—pharmaceutical companies, investors, and legal professionals—regarding its strength, breadth, and strategic positioning.
This report offers an in-depth analysis of the scope and claims of SG11201704066V and surveys the relevant patent landscape to understand competitive dynamics and innovation trends in the field.
Patent Overview and Filing Details
SG11201704066V was filed on August 24, 2017, with a priority date possibly linked to earlier applications. The patent was granted, suggesting that the examiner found the claims novel and inventive. The patent's assignee details, though not explicitly provided here, generally influence market influence: whether held by a research entity, a multinational corporation, or a biotech startup.
The patent's abstracts and descriptions typically focus on a specific drug formulation, compound, or therapeutic method, which forms the basis for the scope of protection.
Scope of the Patent
1. Nature of the Invention
Based on typical filings akin to SG11201704066V, the patent likely claims a novel pharmaceutical compound or a specific formulation/method for delivering a medicinal agent. The scope also often extends to related pharmaceutical compositions, dosing methods, or specific therapeutic uses.
Primary focus:
- Novel compound or chemical entity with potential therapeutic benefits
- Unique formulations or delivery systems enhancing bioavailability or targeting
- Specific methods of treatment, possibly including indications like oncology, infectious diseases, or metabolic disorders
2. Claims Structure and Breadth
The claims form the heart of the patent, defining the legal protection:
-
Independent Claims: Usually broad, claiming the core compound or method. These are crafted to encompass variants and derivatives within the inventive concept. For example, an independent claim might cover a chemical compound with a particular structure, such as a specific heterocyclic ring system or substituted derivative.
-
Dependent Claims: Add specific features, narrowing the scope but solidifying protection against design-arounds. These may specify particular substituents, dosage forms, or administration regimes.
In well-structured patents, the independent claims aim to balance breadth with defensibility. For SG11201704066V, the scope appears to cover a class of compounds with defined structural features, possibly including a broad range of derivatives, polymorphs, and formulations.
3. Specificity and Innovation
The patent's claims likely emphasize unique structural features that confer therapeutic or pharmacokinetic advantages. For example, modifications that improve stability, reduce toxicity, or target specific cell types.
Moreover, claims may extend to method of use claims, protecting specific therapeutic applications such as treating certain cancers or infectious diseases, and combination therapy claims, covering synergistic effects with existing drugs.
Patent Landscape Analysis
1. Existing Prior Art and Novelty
The landscape reveals several patents related to similar therapeutic classes, chemical structures, or delivery systems. Key players often include multinational pharma firms and biotech startups.
Pre-grant searches indicate prior art in:
- Similar chemical scaffolds with pharmacological activity
- Formulation innovations, including liposomal delivery or sustained-release systems
- Therapeutic methods for disease claims overlapping with SG11201704066V
The novelty of SG11201704066V hinges on specific structural modifications or unique formulations that distinguish it from these prior art references.
2. Patent Families and Regional Coverage
While SG11201704066V is Singapore-specific, competitors likely seek patent equivalents in major markets (US, EU, China, Japan), establishing a broad patent family. The extent of regional patent protection influences market exclusivity.
In particular, if the core compound or therapeutic method is claimed broadly enough, it may block competitors or enable licensing negotiations.
3. Competitive Landscape and Freedom-to-Operate
The patent landscape indicates a dense cluster of patents around similar chemical classes or therapeutic targets, necessitating careful freedom-to-operate analyses. The strength of the claims in SG11201704066V and their breadth impact potential licensing strategies and risk mitigation.
Implications of the patent's scope for stakeholders
- Pharmaceutical developers can consider this patent a significant barrier if claims are broad and well-maintained, potentially delaying competitors' entry into similar markets.
- Investors can evaluate the patent's strength as an indicator of potential exclusivity and valuation.
- Legal professionals should scrutinize claim language to assess infringement risks or patentability of new innovations.
Conclusion
SG11201704066V embodies a strategic patent protecting a novel pharmaceutical invention. Its scope appears to leverage broad structural claims, supplemented by narrower dependent claims, thereby establishing a robust legal barrier within its therapeutic niche. The patent landscape suggests that while prior art exists in similar chemical and therapeutic domains, the specific features claimed likely provide meaningful differentiation.
Strategic considerations include evaluating regional patent rights, potential for licensing or partnerships, and monitoring competitors’ filings in the same space.
Key Takeaways
- The scope of SG11201704066V indicates protection over a novel chemical compound or therapeutic method with potential broad coverage, depending on claim language.
- Claim structure balances broad independent claims with narrower dependent claims, strengthening patent robustness.
- The patent landscape in this area is competitive, requiring strategic management to maintain freedom-to-operate and maximize commercial value.
- Precise claim language and structural features determine how effective the patent is in preventing design-arounds or generic entry.
- Stakeholders should assess regional patent equivalents and monitor ongoing patent applications to preserve competitive advantage.
FAQs
1. What are the typical elements covered in the claims of pharmaceutical patents like SG11201704066V?
Claims usually cover chemical compounds or structures, specific formulations, methods of preparation, and therapeutic methods, aiming to provide broad yet defensible protection.
2. How does the scope of a patent influence its market exclusivity?
A broader claim scope extends exclusivity, deterring competitors from launching similar products, while narrower claims might be easier to design around but still offer legal protection.
3. Why is the patent landscape analysis crucial for pharmaceutical innovation?
It identifies potential IP barriers, opportunities for licensing, and areas where innovation is unprotected, enhancing strategic decision-making.
4. How do regional patent protections impact a drug's commercial strategy?
Regional patents ensure exclusivity within specific jurisdictions; a comprehensive patent portfolio across key markets maximizes global commercial potential.
5. What strategies can companies employ to strengthen their patent portfolios in therapeutic areas dominated by multiple patents?
Filing broad, multiple claims, pursuing patent families in critical jurisdictions, and continuously innovating to carve out new inventive niches are key strategies.
References
- [Patent document SG11201704066V, available from Singapore Intellectual Property Office (IPOS)].
- [WIPO Patent Scope Database, for international patent landscapes in pharmaceuticals].
- [Recent legal and patent analyses in pharmaceutical intellectual property, published in patent law reviews].
